Ms. Rizkalla has significant experience in complicated mass tort litigations, having successfully pursued cases involving:
- Complex business litigation
- Partnership dissolutions
Ms. Rizkalla began her career representing Fortune 500 companies, but now fights for individuals who were hurt by large corporations and need the best possible legal representation. She has been appointed Liaison Counsel for the In Re Zoloft Birth Defects JCCP and the In Re Cymbalta Withdrawals JCCP, and is currently Co-Lead Counsel for the In Re Xarelto JCCP and a Plaintiffs’ Steering Committee Member for the In Re Pradaxa JCCP. Ms. Rizkalla has also litigated in large pharmaceutical multi-district litigations. She currently serves on the Corporate Acquisitions Committee and the Science Committee in the Bair Hugger Forced Air Warming Products Liability Litigation (MDL 2666).